​

Overview

Intellectual property & trade is a topic in the health domain with significant developments in policy, regulation, and public health impact.

Key developments include us blocks un pandemic preparedness declaration, drawing criticism from health experts, pharmaceutical industry faces $500 billion patent cliff between 2026 and 2032, us weighs allowing most pharma licensing deals with china, among other significant events and policy changes.


Comments (0)
Loading comments...